We are live on ! Find out more
SYNB

Putnam BioRevolution ETF
SYNB

Delisted

SYNB was delisted on the 13th of November, 2025.

Back to rankings

3 hedge funds and large institutions have $3.64M invested in Putnam BioRevolution ETF in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3 → 3 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

1.95% less ownership

Funds ownership: 77.67% → 75.72% (-1.9%)

6% less capital invested

Capital invested by funds: $3.88M → $3.64M (-$237K)

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$99K

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$197K
Name Holding Trade Value Shares
Change 		Change in
Stake
PI
1
Putnam Investments
Massachusetts
$3.34M – – –
Jane Street
2
Jane Street
New York
$299K +$99K +3,555 +47%
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$3K -$197K -7,064 -98%

SYNB Hedge Fund Activity: Q3 2023 in Review

3 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Putnam BioRevolution ETF (SYNB) for Q3 2023, worth a combined $3.64M — down 6.1% from $3.88M a quarter earlier.

Fund positioning in SYNB was balanced in Q3 2023: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Jane Street, adding an estimated $99K. The largest seller was Royal Bank of Canada, cutting an estimated $197K.

  • 3 institutional investors held Putnam BioRevolution ETF (SYNB) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $3.64M of Putnam BioRevolution ETF stock for Q3 2023, down 6.1% quarter-over-quarter.
  • 0 funds opened new Putnam BioRevolution ETF positions in Q3 2023 and 0 closed out.
  • The largest Putnam BioRevolution ETF buyer in Q3 2023 was Jane Street, an estimated $99K added.
  • The largest Putnam BioRevolution ETF seller in Q3 2023 was Royal Bank of Canada, an estimated $197K sold.

Based on aggregated 13F filings for Q3 2023.